Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I R Smith

Showing results (31-40 of 38) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 38 results.
Carcinogenesis|December 1, 1991
Loss of glutathione S-transferases in pollution-associated liver neoplasms in white suckers (Catostomus commersoni) from Lake OntarioM J Stalker, G M Kirby, T E Kocal, et al.
European Journal of Pharmacology|January 6, 1987
Evidence for low brain penetration by the H1-receptor antagonist temelastine (SK&F 93944)C R Calcutt, C R Ganellin, B Jackson, et al.
The Science of the Total Environment|May 1, 1990
Pathogenesis of skin and liver neoplasms in white suckers from industrially polluted areas in Lake OntarioM A Hayes, I R Smith, T H Rushmore, et al.
The Review of Scientific Instruments|April 3, 2012
Simple and compact capacitive voltage probe for measuring voltage impulses up to 0.5 MVR Pecquois, L Pecastaing, A de Ferron, et al.
Agents and Actions|October 1, 1986
N-Methyldimaprit (SK&F92054). A chemical control for the histamine H2-receptor agonist dimapritR C Blakemore, C R Ganellin, B K Leigh, et al.
Journal of Medicinal Chemistry|March 1, 1988
Development of a new physicochemical model for brain penetration and its application to the design of centrally acting H2 receptor histamine antagonistsR C Young, R C Mitchell, T H Brown, et al.
British Journal of Pharmacology|January 1, 1988
Zolantidine (SK&F 95282) is a potent selective brain-penetrating histamine H2-receptor antagonistC R Calcutt, C R Ganellin, R Griffiths, et al.
Internal Medicine Journal|April 5, 2012
Queensland Lung Cancer Screening Study: rationale, design and methodsH M Marshall, R V Bowman, J Crossin, et al.
Pageof 4

Showing results (31-40 of 38) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 38 results.
Carcinogenesis|December 1, 1991
Loss of glutathione S-transferases in pollution-associated liver neoplasms in white suckers (Catostomus commersoni) from Lake OntarioM J Stalker, G M Kirby, T E Kocal, et al.
European Journal of Pharmacology|January 6, 1987
Evidence for low brain penetration by the H1-receptor antagonist temelastine (SK&F 93944)C R Calcutt, C R Ganellin, B Jackson, et al.
The Science of the Total Environment|May 1, 1990
Pathogenesis of skin and liver neoplasms in white suckers from industrially polluted areas in Lake OntarioM A Hayes, I R Smith, T H Rushmore, et al.
The Review of Scientific Instruments|April 3, 2012
Simple and compact capacitive voltage probe for measuring voltage impulses up to 0.5 MVR Pecquois, L Pecastaing, A de Ferron, et al.
Agents and Actions|October 1, 1986
N-Methyldimaprit (SK&F92054). A chemical control for the histamine H2-receptor agonist dimapritR C Blakemore, C R Ganellin, B K Leigh, et al.
Journal of Medicinal Chemistry|March 1, 1988
Development of a new physicochemical model for brain penetration and its application to the design of centrally acting H2 receptor histamine antagonistsR C Young, R C Mitchell, T H Brown, et al.
British Journal of Pharmacology|January 1, 1988
Zolantidine (SK&F 95282) is a potent selective brain-penetrating histamine H2-receptor antagonistC R Calcutt, C R Ganellin, R Griffiths, et al.
Internal Medicine Journal|April 5, 2012
Queensland Lung Cancer Screening Study: rationale, design and methodsH M Marshall, R V Bowman, J Crossin, et al.
Pageof 4